LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 65 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2020. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |